These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11653874)
21. Ethical and legal considerations in dental caries research involving human subjects. Branson R J Dent Res; 1980 Jul; 59(Special Issue C):1214-364. PubMed ID: 11651755 [No Abstract] [Full Text] [Related]
22. Testing drugs in pediatric populations: the FDA mandate. Tauer CA Account Res; 1999; 7(1):37-58. PubMed ID: 11657562 [No Abstract] [Full Text] [Related]
23. Why the tolerance of potential harms? Research ethics in Alzheimer disease. Post SG Account Res; 1999; 7(2-4):241-53. PubMed ID: 11658179 [No Abstract] [Full Text] [Related]
24. Ethics committees: local and national. Powell D BMJ; 1989 Mar; 298(6675):747-8. PubMed ID: 11644408 [No Abstract] [Full Text] [Related]
25. American IRBs and Dutch research ethics committees: how they compare. Bergkamp L IRB; 1988; 10(5):1-6. PubMed ID: 11650072 [No Abstract] [Full Text] [Related]
26. How an investigator and an IRB cooperated in research design. Benotti JR; Shannon TA IRB; 1982; 4(6):6-7. PubMed ID: 11649187 [No Abstract] [Full Text] [Related]
27. IRBs and pharmaceutical company funding of research. Jellinek MS; Levine RJ IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693 [No Abstract] [Full Text] [Related]
28. The quality of mercy. Crigger BJ Hastings Cent Rep; 1993; 23(3):3. PubMed ID: 11643129 [No Abstract] [Full Text] [Related]
29. Demarcating research and treatment interventions: a case illustration. Goldberg JL; Phillips JO; Freedman B; Weijer C IRB; 1992; 14(4):5-8. PubMed ID: 11651393 [No Abstract] [Full Text] [Related]
30. The changing clinical trials scene: the role of the IRB. Mitchell SC; Steingrub J IRB; 1988; 10(4):1-5. PubMed ID: 11650078 [No Abstract] [Full Text] [Related]
31. The Deschamps Report: controls for clinical research in Quebec. Miller J J Int Bioethique; 1997; 8(1-2):79-85. PubMed ID: 11655382 [No Abstract] [Full Text] [Related]
32. Multicenter trials and subject eligibility: should local IRBs play a role? Freedman B IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320 [No Abstract] [Full Text] [Related]
33. National, independent oversight: reinforcing the safety net for human subjects research. Mastroianni AC Account Res; 1999; 7(2-4):303-9. PubMed ID: 11658185 [No Abstract] [Full Text] [Related]
34. Much more research to fall under IRB review. Maloney DM Hum Res Rep; 1999 Jul; 14(7):3. PubMed ID: 11658059 [No Abstract] [Full Text] [Related]
35. Review of Australia's ethics committees. Coney S Lancet; 1994 Sep; 344(8925):811. PubMed ID: 11644614 [No Abstract] [Full Text] [Related]
36. The paradoxical case of payment as benefit to research subjects. Macklin R IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related]
37. An introduction to NBAC's report on research involving persons with mental disorders that may affect decisionmaking capacity. Childress JF Account Res; 1999; 7(2-4):101-15. PubMed ID: 11658169 [No Abstract] [Full Text] [Related]
38. Protection of human subjects. U.S. Department of Health and Human Services Code Fed Regul Public Welfare; 1995 Oct; Title 45(Sections 46-101 to 46-409):. PubMed ID: 11686173 [No Abstract] [Full Text] [Related]
39. Ethics of drug experimentation. Sgreccia E Dolentium Hominum; 1987; 4(2nd Yr. 1):60-75. PubMed ID: 11653200 [No Abstract] [Full Text] [Related]
40. Monitoring of drug tests is faulted. Eichenwald K N Y Times Web; 1998 Jun; ():A14. PubMed ID: 11647564 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]